Metallothionein 2A interacts with the kinase domain of PKCμ in prostate cancer

Biochemical and Biophysical Research Communications

Volumn 310, Issue 3, 2003, Pages 1032-1038

  Rao, Prema S ^a   Jaggi, Meena ^a   Smith, David J ^a   Hemstreet, George P ^a   Balaji, K C ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Androgen; Androgen independent; Chemotherapy; Metallothionein; PKC; Prostate cancer; Protein kinase C ; Protein protein interaction

Indexed keywords

METALLOTHIONEIN; PEPTIDE LIBRARY; PROTEIN KINASE C;

ARTICLE; ASSAY; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; TWO HYBRID SYSTEM; YEAST;

EID: 0141645231     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.09.118     Document Type: Article

References (29)

1. Hellerstedt B.A., Pienta K.J. The current state of hormonal therapy for prostate cancer. CA Cancer J. Clin. 52:2002;154-179.
2. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics, 2003. CA Cancer J. Clin. 53:2003;5-26.
3. Eisenberger M. Chemotherapy for hormone-resistant prostate cancer. Walsh P.C., Retik A.B., Vaughan D.E., Wein A.J. Campbells Urology. 3:1998;2645-2658.
4. Lamb D.J., Buttyan R. Editorial: hormone therapies for prostate cancer - acute disease control, chronic disease progression. J. Urol. 169:2003;1558.
5. Jaggi M., Rao P.S., Smith D.J., Hemstreet G.P., Balaji K.C. Protien kinase C μ is down regulated in androgen-independent prostate cancer. Biochem. Biophys. Res. Commun. 307:2003;254-260.
6. Storz P., Hausser A., Link G., Dedio J., Ghebrehiwet B., Pfizenmaier K., Johannes F.J. Protein kinase C μ is regulated by the multifunctional chaperon protein p32. J. Biol. Chem. 275:2000;24601-24607.
7. Prestle J., Pfizenmaier K., Brenner J., Johannes F.J. Protein kinase C mu is located at the Golgi compartment. J. Cell Biol. 134:1996;1401-1410.
8. Powell C.T., Brittis N.J., Stec D., Hug H., Heston W.D., Fair W.R. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ. 7:1996;419-428.
9. Waldron R.T., Iglesias T., Rozengurt E. The pleckstrin homology domain of protein kinase D interacts preferentially with the eta isoform of protein kinase C. J. Biol. Chem. 274:1999;9224-9230.
10. Coyle P., Philcox J.C., Carey L.C., Rofe A.M. Metallothionein: the multipurpose protein. Cell. Mol. Life Sci. 59:2002;627-647.
11. Palmiter R.D. The elusive function of metallothioneins. Proc. Natl. Acad. Sci. USA. 95:1998;8428-8430.
12. Suzuki K.T. Structure and function of metallothionein. Nippon Rinsho. 54:1996;33-39.
13. Webber M.M., Rehman S.M., James G.T. Metallothionein induction and deinduction in human prostatic carcinoma cells: relationship with resistance and sensitivity to adriamycin. Cancer Res. 48:1988;4503-4508.
14. Abdel-Mageed A.B., Agrawal K.C. Activation of nuclear factor kappaB: potential role in metallothionein-mediated mitogenic response. Cancer Res. 58:1998;2335-2338.
15. Vasak M., Hasler D.W. Metallothioneins: new functional and structural insights. Curr. Opin. Chem. Biol. 4:2000;177-183.
16. Johannes F.J., Prestle J., Eis S., Obehagemann P., Pfizenmaier K. PKCμ is a novel, atypical member of the protein kinase C family. J. Biol. Chem. 269:1994;6140-6148.
17. Garrett S.H., Sens M.A., Shukla D., Flores L., Somji S., Todd J.H., Sens D.A. Metallothionein isoform 1 and 2 gene expression in the human prostate: downregulation of MT-1X in advanced prostate cancer. Prostate. 43:2000;125-135.
18. Waldron R.T., Rozengurt E. Protein kinase C phosphorylates protein kinase D activation loop Ser744 and Ser748 and releases autoinhibition by the pleckstrin homology domain. J. Biol. Chem. 278:2003;154-163.
19. Henttu P., Vihko P. The protein kinase C activator, phorbol ester, elicits disparate functional responses in androgen-sensitive and androgen-independent human prostatic cancer cells. Biochem. Biophys. Res. Commun. 244:1998;167-171.
20. Tekur S., Ho S.M. Ribozyme-mediated downregulation of human metallothionein II(a) induces apoptosis in human prostate and ovarian cancer cell lines. Mol. Carcinog. 33:2002;44-55.
21. Moussa M., Kloth D., Peers G., Cherian M.G., Frei J.V., Chin J.L. Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen. Clin. Invest. Med. 20:1997;371-380.
22. Zhang X.H., Jin L., Sakamoto H., Takenaka I. Immunohistochemical localization of metallothionein in human prostate cancer. J. Urol. 156:1996;1679-1681.
23. Tohyama C., Suzuki J.S., Homma S., Karasawa M., Kuroki T., Nishimura H., Nishimura N. Testosterone-dependent induction of metallothionein in genital organs of male rats. Biochem. J. 317:1996;97-102.
24. Toker A. Signaling through protein kinase C. Front. Biosci. 3:1998;D1134-D1147.
25. Songyang Z., Lu K.P., Kwon Y.T., Tsai L.H., Filhol O., Cochet C., Brickey D.A., Soderling T.R., Bartleson C., Graves D.J., DeMaggio A.J., Hoekstra M.F., Blenis J., Hunter T., Cantley L.C. A structural basis for substrate specificities of protein Ser/Thr kinases: primary sequence preference of casein kinases I and II, NIMA, phosphorylase kinase, calmodulin-dependent kinase II, CDK5, and Erk1. Mol. Cell. Biol. 16:1996;6486-6493.
26. Nishikawa K., Toker A., Johannes F.J., Songyang Z., Cantley L.C. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 272:1997;952-960.
27. Blom N., Gammeltoft S., Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294:1999;1351-1362.
28. Johannes F.J., Hausser A., Storz P., Truckenmuller L., Link G., Kawakami T., Pfizenmaier K. Bruton's tyrosine kinase (Btk) associates with protein kinase C mu. FEBS Lett. 461:1999;68-72.
29. Hausser A., Storz P., Link G., Stoll H., Liu Y.C., Altman A., Pfizenmaier K., Johannes F.J. Protein kinase C mu is negatively regulated by 14-3-3 signal transduction proteins. J. Biol. Chem. 274:1999;9258-9264.